ARCHIVES

NCI Not Following Congress Mandate, Zubrod Contends

This article is from The Cancer Letter archive.

Vol. 04 No. 17 | April 28, 1978

Download PDF Visit The Full Archive

Related Articles

Recommendations For Adjuvant Therapy In Breast Cancer

September 20, 1985

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008

ACS Approves 127 Cancer Programs; Total Now 994

March 18, 1983

Clearinghouse Finds Eight Carcinogens

July 7, 1978

In Brief: OSCC Staff Appointments Announced Report Available On Chemical Disposal Health Aspects

August 3, 1984

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

April 25, 2014